GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » PB Ratio

Hanall Biopharma Co (XKRX:009420) PB Ratio : 9.31 (As of May. 10, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-10), Hanall Biopharma Co's share price is ₩34200.00. Hanall Biopharma Co's Book Value per Share for the quarter that ended in Dec. 2023 was ₩3,673.45. Hence, Hanall Biopharma Co's PB Ratio of today is 9.31.

The historical rank and industry rank for Hanall Biopharma Co's PB Ratio or its related term are showing as below:

XKRX:009420' s PB Ratio Range Over the Past 10 Years
Min: 2.28   Med: 6.89   Max: 17.95
Current: 9.31

During the past 13 years, Hanall Biopharma Co's highest PB Ratio was 17.95. The lowest was 2.28. And the median was 6.89.

XKRX:009420's PB Ratio is ranked worse than
93.93% of 955 companies
in the Drug Manufacturers industry
Industry Median: 2.01 vs XKRX:009420: 9.31

During the past 12 months, Hanall Biopharma Co's average Book Value Per Share Growth Rate was 10.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hanall Biopharma Co was 24.00% per year. The lowest was -6.40% per year. And the median was 6.45% per year.

Back to Basics: PB Ratio


Hanall Biopharma Co PB Ratio Historical Data

The historical data trend for Hanall Biopharma Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co PB Ratio Chart

Hanall Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.23 10.59 6.59 5.36 12.06

Hanall Biopharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.36 5.61 5.93 8.37 12.06

Competitive Comparison of Hanall Biopharma Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanall Biopharma Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's PB Ratio falls into.



Hanall Biopharma Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Hanall Biopharma Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=34200.00/3673.446
=9.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Hanall Biopharma Co  (XKRX:009420) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Hanall Biopharma Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co (XKRX:009420) Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines